Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Net Margin (2016 - 2025)

Phibro Animal Health has reported Net Margin over the past 14 years, most recently at 7.34% for Q4 2025.

  • Quarterly results put Net Margin at 7.34% for Q4 2025, up 631.0% from a year ago — trailing twelve months through Dec 2025 was 6.29% (up 563.0% YoY), and the annual figure for FY2025 was 3.72%, up 466.0%.
  • Net Margin for Q4 2025 was 7.34% at Phibro Animal Health, up from 7.29% in the prior quarter.
  • Over the last five years, Net Margin for PAHC hit a ceiling of 7.5% in Q4 2021 and a floor of 4.12% in Q2 2024.
  • Median Net Margin over the past 5 years was 3.0% (2022), compared with a mean of 2.98%.
  • Biggest five-year swings in Net Margin: tumbled -512bps in 2023 and later skyrocketed 866bps in 2025.
  • Phibro Animal Health's Net Margin stood at 7.5% in 2021, then crashed by -61bps to 2.95% in 2022, then crashed by -83bps to 0.51% in 2023, then soared by 102bps to 1.03% in 2024, then skyrocketed by 613bps to 7.34% in 2025.
  • The last three reported values for Net Margin were 7.34% (Q4 2025), 7.29% (Q3 2025), and 4.55% (Q2 2025) per Business Quant data.